DEEPECHO
Overview
DeepEcho is an AI-first healthtech company dedicated to transforming prenatal care through advanced AI-powered solutions. Their core offering is a cloud-based standalone software as a medical device (SaMD) that significantly enhances fetal ultrasound diagnostics. The AI solution leverages deep learning algorithms to automate the real-time identification of fetal ultrasound views, provide computer-assisted diagnosis, and suggest precise biometrical measurements, including Head Circumference (HC), Bi-parietal Diameter (BPD), Femur Length (FL), Abdominal Circumference (AC), Gestational Age (GA), and Estimated Fetal Weight (EFW).
The technology is designed to address critical challenges in healthcare, such as time constraints, diagnostic variability among practitioners, and the global shortage of skilled radiologists, particularly in underserved regions. By mimicking the expertise of a trained sonographer, DeepEcho’s platform enables both experienced clinicians to improve efficiency and accuracy, and minimally trained healthcare workers to perform high-quality prenatal scans. DeepEcho is committed to making early, accurate prenatal diagnosis universally accessible, ultimately aiming to prevent birth defects, address preterm birth, and reduce low birth weight outcomes.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated Fetal measurements (HC, BPD, FL, AC, GA, EFW)
- Computer-assisted ultrasound diagnosis
- Real-time identification of fetal ultrasound views
- Guidance for standardized probe sweeps (BlindSweep protocol)
- AI expertise at the service of medical professionals
- Teleguidance and remote diagnosis support
- Fast screening (3 to 5x faster)
- Precise diagnosis (>95% accuracy)
- Hardware agnostic
- Seamless workflow integration
Use Cases
- Enhancing fetal ultrasound diagnostics
- Preventing birth defects
- Addressing preterm birth and low birth weight
- Improving access to quality prenatal care in underserved regions
- Assisting minimally trained clinicians in performing high-quality ultrasound diagnoses
- Reducing diagnostic variability and time constraints for trained sonographers
What Physicians Need to Know
DEEPECHO offers significant advantages for clinicians by enhancing efficiency for experienced sonographers through automated measurements and standard plane identification. For healthcare workers with limited training, it provides real-time guidance and the confidence to perform accurate fetal assessments, democratizing access to quality prenatal care. The FDA 510(k) clearance for its fetal ultrasound analysis platform and Breakthrough Device Designation for its Blind Sweep Platform underscore its clinical validity and potential to transform prenatal care. This technology can help address workforce shortages and increase patient throughput, allowing obstetricians to focus on high-risk cases.
DEEPECHO's solution is designed to be scalable, mobile, and hardware-agnostic, allowing for flexible deployment across various healthcare settings. The company has partnered with Butterfly Network to develop an AI guidance solution compatible with Butterfly's handheld ultrasound system. Additionally, DEEPECHO is collaborating with Microsoft to make its algorithms available on the Azure Healthcare platform.
Details
| Category | OB/GYN AI, Radiology & Imaging AI |
| Pricing | Contact for quote |
| Deployment | Cloud-based standalone software as a medical device (SaMD) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated DeepEcho received FDA 510(k) clearance (K242594) on May 23, 2025, for its cloud-based standalone software as a medical device (SaMD). The device assists qualified healthcare professionals in assessing obstetrical images by identifying fetal ultrasound views, suggesting caliper placement, and computing biometrical measurements. |
| Integrations | |
| EHR | Not specified |
| Specialties | Maternal-Fetal Medicine, Obstetrics & Gynecology, Radiology |
What the Web Says
DeepEcho is an AI-first health technology company focused on revolutionizing prenatal care through its fetal ultrasound analysis platform. The platform automates fetal ultrasound imaging by recognizing standard views, segmenting anatomical structures, and computing biometric measurements, aiming to reduce operator variability and streamline workflow. DeepEcho has received FDA 510(k) clearance for its platform and has been recognized by TIME and Statista as one of the World's Top HealthTech Companies for 2025.
Overall: PositiveStrengths
- Automates fetal ultrasound imaging, enhancing diagnostic accuracy and efficiency.
- Reduces operator variability and streamlines workflow.
- Provides real-time guidance, enabling healthcare workers with limited training to perform scans.
- Models perform with consistency that matches or exceeds human sonographers.
- Aims to democratize access to quality fetal ultrasound, especially in underserved areas.
- Fast screening (3 to 5 times faster) and precise diagnosis (>95% accuracy).
Limitations
- Claims, figures, and metrics on the website are not yet validated by the FDA.
- Some users might find the initial setup challenging due to the complexity of features (referencing general AI platforms, not specific to DeepEcho).
- Potential for overwhelming content or difficulty finding relevant feedback (referencing general review platforms like Capterra).
Based on reviews from: TIME & Statista, Femtech Insider, Newswire, DeepEcho Official Website, G2, Capterra
Last updated: 2026-07-17
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate DEEPECHO
Videos
Product demos, reviews, and walkthroughs for DEEPECHO.
Deepecho Demo
